FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methotrexate Injection
Status: Discontinuation
»Therapeutic Categories: Oncology; Pediatric

Expand all

Mylan Institutional (New 01/25/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Methotrexate 25 mg/mL, 2 mL SDV, 5PK (NDC 67457-467-99) 01/25/2018 The discontinuation of this product is a business decision and not related to product quality, safety or efficacy
Methotrexate 25 mg/mL, 4 mL SDV, 10PK (NDC 67457-486-99) 01/25/2018 The discontinuation of this product is a business decision and not related to product quality, safety or efficacy
Methotrexate 25 mg/mL, 8 mL SDV, 10PK (NDC 67457-485-99) 01/25/2018 The discontinuation of this product is a business decision and not related to product quality, safety or efficacy

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English